These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2198178)

  • 21. Effect of beta-mimetic tocolysis on cervical ripening and plasma prostaglandin F2 alpha metabolite after endocervical application of prostaglandin E2.
    Goeschen K; Fuchs AR; Fuchs F; Rasmussen AB; Rehnström JV; Saling E
    Obstet Gynecol; 1985 Feb; 65(2):166-71. PubMed ID: 2857479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of the anti-progestin mifepristone (RU 486) on plasma prostaglandin metabolite levels in early pregnancy and its influence on pregnancy termination.
    Hill NC; López Bernal A; Ferguson J; MacKenzie IZ
    Acta Obstet Gynecol Scand; 1990; 69(4):321-5. PubMed ID: 2244464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma prostaglandin metabolite concentrations in normal and dysfunctional labour.
    Johnston TA; Greer IA; Kelly RW; Calder AA
    Br J Obstet Gynaecol; 1993 May; 100(5):483-8. PubMed ID: 8518251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma concentrations of prostaglandin F2 alpha and prostaglandin E2 metabolites after transabdominal and transvaginal cervical cerclage.
    Novy MJ; Ducsay CA; Stanczyk FZ
    Am J Obstet Gynecol; 1987 Jun; 156(6):1543-52. PubMed ID: 3473937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doppler velocimetry of the uterine and fetal circulations during prostaglandin E2 cervical ripening.
    Rotmensch S; Liberati M; Celentano C; Bellati U; Tiboni GM; Ben-Rafael Z
    Ultrasound Obstet Gynecol; 1996 Nov; 8(5):333-6. PubMed ID: 8978008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of intracervical administration of a prostaglandin E2 gel in pregnant and non-pregnant heifers.
    Duchens M; Fredriksson G; Kindahl H; Aiumlamai S
    Vet Rec; 1993 Nov; 133(22):546-9. PubMed ID: 8116158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaginal and intracervical prostaglandin E2 for cervical ripening: a Doppler study of hemodynamic effects.
    Polvi HJ; Pirhonen JP; Erkkola RU
    Am J Perinatol; 1994 Sep; 11(5):337-9. PubMed ID: 7993512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandins in preinduction cervical ripening. Meta-analysis of worldwide clinical experience.
    Keirse MJ
    J Reprod Med; 1993 Jan; 38(1 Suppl):89-100. PubMed ID: 8429533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervical priming prior to dilatation and evacuation: a comparison of methods.
    Lauersen NH; Den T; Iliescu C; Wilson KH; Graves ZR
    Am J Obstet Gynecol; 1982 Dec; 144(8):890-4. PubMed ID: 7148920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical ripening with intracervical prostaglandin-E2 gel. I. Clinical results and effect on plasma levels of oxytocin and 13,14-dihydro,15-ketoprostaglandin-F2 alpha.
    Fuchs AR; Goeschen K; Rasmussen AB; Rehnström JV; Saling E; Fuchs F
    Am J Perinatol; 1983 Oct; 1(1):64-9. PubMed ID: 6596103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The use of prostaglandin E2 to induce labor and abortion in the second trimester].
    Khadzhiev A
    Akush Ginekol (Sofiia); 1991; 30(1):39-45. PubMed ID: 1793135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of four methods of ripening the unfavourable cervix.
    Wilson PD
    Br J Obstet Gynaecol; 1978 Dec; 85(12):941-4. PubMed ID: 367426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local administration of prostaglandin E2 for cervical ripening and labor induction: the appropriate route and dose.
    Nuutila M; Kajanoja P
    Acta Obstet Gynecol Scand; 1996 Feb; 75(2):135-8. PubMed ID: 8604599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical ripening and uterine contraction induced by prostaglandin E2-gel in pregnant Japanese monkeys (Macaca fuscata fuscata).
    Shimizu K; Nozaki M; Oshima K
    J Med Primatol; 1994 Jan; 23(1):23-31. PubMed ID: 7932635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravaginal misoprostol as a cervical ripening agent.
    Fletcher HM; Mitchell S; Simeon D; Frederick J; Brown D
    Br J Obstet Gynaecol; 1993 Jul; 100(7):641-4. PubMed ID: 8369246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral prostaglandin metabolite levels in women undergoing therapeutic abortions in the first trimester with and without treatment with prostaglandin synthetase inhibitor.
    Wolfe WM; Rao CV; McCracken EM; Demers LM
    Prostaglandins Leukot Med; 1987 Jun; 28(1):53-9. PubMed ID: 3112807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preinduction cervical ripening: a randomized prospective comparison of the efficacy and safety of intravaginal and intracervical prostaglandin E2 gel.
    Stempel JE; Prins RP; Dean S
    Am J Obstet Gynecol; 1997 Jun; 176(6):1305-9; discussion 1309-12. PubMed ID: 9215189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic considerations for preinduction cervical ripening with intracervical prostaglandin E2 gel.
    Bernstein EP
    J Reprod Med; 1993 Jan; 38(1 Suppl):73-7. PubMed ID: 8429530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ripening of the unfavorable cervix with prostaglandin E2: intracervical versus intravaginal route.
    Herabutya Y; O-Prasertsawat P
    J Med Assoc Thai; 1993 Jan; 76 Suppl 1():63-8. PubMed ID: 8113660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological modulation of cervical compliance in the first and second trimesters of pregnancy.
    Calder AA; Greer IA
    Semin Perinatol; 1991 Apr; 15(2):162-72. PubMed ID: 1876872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.